BRIEF published on 02/21/2025 at 17:50, 1 year 6 months ago Guerbet : Mise à jour des actions et droits de vote au 31 janvier 2025 Droits De Vote Actions AMF Transparence Guerbet
BRIEF published on 02/21/2025 at 17:50, 1 year 6 months ago Guerbet: Update of shares and voting rights as of January 31, 2025 Voting Rights Actions AMF Transparency Guerbet
PRESS RELEASE published on 02/21/2025 at 17:45, 1 year 6 months ago GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2025 Déclaration du nombre de droits de vote et d'actions composant le capital de la société conformément aux réglementations en vigueur Déclaration Droits De Vote Actions Réglementation Société
BRIEF published on 02/03/2025 at 12:05, 1 year 7 months ago Guerbet Appoints NATIXIS ODDO BHF for Liquidity Contract Euronext Paris Liquidity Contract NATIXIS ODDO BHF Guerbet Financial Markets
BRIEF published on 02/03/2025 at 12:05, 1 year 7 months ago Guerbet confie à NATIXIS ODDO BHF le mandat de son contrat de liquidité Euronext Paris NATIXIS ODDO BHF Contrat De Liquidité Guerbet Marchés Financiers
PRESS RELEASE published on 02/03/2025 at 12:00, 1 year 7 months ago GUERBET : Implementation of a Liquidity Contract with NATIXIS ODDO BHF Guerbet ends current liquidity contract and appoints NATIXIS and ODDO BHF for a new liquidity contract compliant with AMF guidelines, aiming to improve shares trading on Euronext Paris market Liquidity Contract Natixis ODDO BHF Guerbet Shares Trading
PRESS RELEASE published on 02/03/2025 at 12:00, 1 year 7 months ago GUERBET : Mise en oeuvre d’un nouveau Contrat de Liquidité avec NATIXIS-ODDO BHF Guerbet annonce la mise en œuvre d'un nouveau Contrat de Liquidité avec NATIXIS-ODDO BHF pour ses actions ordinaires sur Euronext Paris Euronext Paris Contrat De Liquidité AMF Guerbet NATIXIS-ODDO BHF
BRIEF published on 01/31/2025 at 17:50, 1 year 7 months ago Guerbet Announces 2025 Financial Agenda Financial Results Financial Agenda Guerbet Medical Imaging 2025
BRIEF published on 01/31/2025 at 17:50, 1 year 7 months ago Guerbet annonce son agenda financier 2025 Résultats Financiers Agenda Financier Guerbet Imagerie Médicale 2025
PRESS RELEASE published on 01/31/2025 at 17:45, 1 year 7 months ago Correction: GUERBET : Financial agenda for 2025 Guerbet announces its financial agenda for 2025 including revenue updates and shareholder meeting schedule Financial Agenda Guerbet Shareholder Meeting 2025 Revenue Updates
Published on 09/11/2026 at 15:25, 1 hour 30 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 1 hour 55 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 2 hours 25 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 13:58, 2 hours 57 minutes ago BlackBerry Radar Advances Asset Intelligence for Transportation
Published on 09/11/2026 at 13:00, 3 hours 55 minutes ago Silver Tiger Intersects 2.1 Metres of 7.72 Kilograms Per Tonne Silver Equivalent in the Caleigh Vein Including 0.53 Metres of 29.62 Kilograms
Published on 09/11/2026 at 16:30, 25 minutes ago Belt and Road Summit in Hong Kong welcomes over 6,200 global leaders to explore new business opportunities
Published on 09/11/2026 at 16:00, 55 minutes ago Deutsche Postbank Funding Trust III published semi-annual report
Published on 09/11/2026 at 16:00, 55 minutes ago Form 8.3 - IPConcept (Luxemburg) S.A.: SONNTAG Premium
Published on 09/11/2026 at 15:29, 1 hour 26 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/11/2026 at 15:24, 1 hour 31 minutes ago Form 8.3 - The Vanguard Group, Inc.: Segro PLC
Published on 09/11/2026 at 07:00, 9 hours 55 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 9 hours 55 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 9 hours 55 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 21 hours 25 minutes ago Availability of the 2026 Interim Financial Report
